Semaglutide has rapidly become a household name for people looking to lose weight or manage type 2 diabetes. This medication, originally developed to help with blood sugar control, is used to control blood sugar levels in adults with type 2 diabetes. It has also shown remarkable results in weight loss, making it a dual purpose powerhouse in modern medicine. At Dr. Parangi's office, we aim to educate our patients about cutting edge treatments like semaglutide, which is one of several prescription medicines used for diabetes and weight management, and help them determine if it's the right fit for their health goals.
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used to control blood sugar levels and for weight management in adults with type 2 diabetes. It is available as a subcutaneous injection and oral tablet, with brand names including Ozempic, Wegovy, and Rybelsus. Originally approved by the FDA in 2017 for type 2 diabetes management, semaglutide gained even more attention in 2021 when a higher dose formulation was approved for chronic weight management. Semaglutide is a prescription medicine and should only be used under the supervision of a healthcare provider. Managing blood sugar and weight with semaglutide can help reduce the risk of blood vessel disease, a serious complication of diabetes and obesity. It also helps with weight loss and reducing the risk of worsening kidney disease.
Patients should inform their healthcare provider about all other medicines, including prescription medicines, over-the-counter drugs, herbal supplements and vitamins as interactions may occur.
Semaglutide works by mimicking the action of the natural hormone GLP-1, which is produced in the gut in response to food intake. GLP-1 plays a crucial role in regulating blood sugar, appetite, and digestion. Here's how semaglutide achieves its effects:
This multifaceted action helps people not only control blood sugar levels and lower high blood sugar, reducing the risk of complications, but also reduce caloric intake and ultimately lose weight.
Semaglutide is available under several brand names, each with different indications and formulations:
Brand | Formulation | Indication | Dosing |
---|---|---|---|
Ozempic | Injection (weekly) | Type 2 diabetes, CV risk reduction | 0.25–2.0 mg weekly |
Wegovy | Injection (weekly) | Weight loss, CV risk reduction | 0.25–2.4 mg weekly |
Rybelsus | Oral tablet (daily) | Type 2 diabetes | 7 mg or 14 mg daily |
Note: Only Novo Nordisk manufactures FDA-approved semaglutide products in the US. There are no generics or other approved brands.
Dosing for semaglutide is carefully titrated to minimize side effects, especially gastrointestinal discomfort. The regimen depends on the brand and indication:
If you have questions about how to inject semaglutide, miss a dose, or experience any issues with administration, call your doctor.
If a dose is missed, patients should take the missed dose as soon as possible, unless it is more than 5 days late for Ozempic or within 48 hours of the next scheduled dose for Wegovy. It is important to take the next dose as scheduled to maintain a regular dosing routine and ensure the medication's effectiveness. Patients should not double doses or take extra medication to make up for a missed dose. If a patient misses a dose for more than 2 weeks, they should call their doctor for guidance on how to proceed. Patients should always follow the dose escalation schedule and consult their healthcare provider if they have any questions.
Semaglutide has been shown in clinical trials and real-world studies to help people lose a significant amount of weight, especially when combined with lifestyle changes like diet and exercise. On average, patients lose about 15% of their body weight over a year or more of treatment.
Like all medications, semaglutide can cause side effects. Most are mild and improve over time, but some may be serious and require medical attention.
Tirzepatide (brand names: Mounjaro for diabetes, Zepbound for weight loss) is a newer medication that has drawn attention for its even greater weight loss and glucose-lowering effects. Both semaglutide and tirzepatide are prescription medicines and should only be used under medical supervision. Here's how they compare:
Feature | Semaglutide | Tirzepatide |
---|---|---|
Drug Class | GLP-1 receptor agonist | Dual GLP-1 and GIP receptor agonist |
Brands | Ozempic, Wegovy, Rybelsus | Mounjaro, Zepbound |
FDA-Approved Uses | Diabetes, weight loss, CV risk, kidney risk | Diabetes, weight loss, OSA |
Dosing | 0.25–2.4 mg weekly (injectable) | 2.5–15 mg weekly (injectable) |
Weight Loss (12 mo) | 8–15% of body weight | 15–20% of body weight |
Onset of Action | Gradual, titrated | Gradual, titrated |
Side Effects | GI: nausea, vomiting, diarrhea | Similar GI side effects, possibly less nausea |
Oral Form Available | Yes (Rybelsus) | No |
Semaglutide is a powerful tool for weight loss and diabetes management, but it's not for everyone. It's best suited for:
To get the most out of semaglutide:
At Dr. Parangi's office we offer comprehensive evaluations to determine if semaglutide is right for you. We monitor your progress, adjust dosages as needed, and provide ongoing support with nutrition and lifestyle coaching. Our medically supervised program is designed to help you get the most out of your treatment safely and effectively.
Dr. Parangi is a board certified doctor providing weight loss services from our office located in Paramus, NJ and is conveniently located throughout Bergen County, including: Paramus, Hackensack, Ridgewood, Englewood, Teaneck, Oradell, Saddle River, Westwood and surrounding areas. With an expanding service area, Dr. Parangi is committed to serve a wide audience in Bergen County.
Ready to take the first step? Call (201) 265-7564 or request an appointment online today to speak with Dr. Parangi about semaglutide treatment in New Jersey. Our office is accepting new patients and same day and next day appointments are available for new patients.
Most people notice reduced appetite and some weight loss within the first month of taking Semaglutide, with more significant results after 3–6 months.
Semaglutide should not be combined with other GLP-1 receptor agonists. Discuss with your doctor before combining with other weight loss drugs.
Take the missed dose as soon as possible within 5 days. If more than 5 days have passed, skip the missed dose and resume your regular schedule with your next dose. If you are unsure what to do or miss multiple doses, call your doctor for guidance.
Coverage varies by plan and indication (weight loss vs. diabetes). Check with your insurer and ask your provider about assistance programs.
Yes, initial lab work helps us understand your baseline health and ensures that any prescribed treatments are safe and effective for you.
If you experience symptoms of low blood sugar (such as shakiness, sweating, or dizziness), quickly consume a fast-acting source of glucose like fruit juice. If symptoms persist or are severe, call your doctor immediately.